Free Trial

10 Best Small Cap Stocks to Buy Now - 1 of 10

 
 

Quince Therapeutics (NASDAQ:QNCX)

Consensus Rating
Strong Buy
Rating Score
3.5
Ratings Breakdown
4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$8.50 (451.9% Upside)

About Quince Therapeutics

Quince Therapeutics logoQuince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises EryDex for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/7/2024Maxim GroupInitiated CoverageBuy$6.00
10/29/2024RODMAN&RENSHAWUpgradeStrong-Buy
10/29/2024Rodman & RenshawInitiated CoverageBuy$11.00
10/22/2024EF Hutton Acquisition Co. IUpgradeStrong-Buy
 

625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here